The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So the pain is there, but there isn't an invitation to focus on it. And that's probably one of the differences with classic psychedelic therapy versus MDMA therapy. Arguably, MDMA therapy is more like it's a bit closer to traditional talk therapy where there is more dialogue. People are able to talk on MDMA.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.